Ian L Ross
Overview
Explore the profile of Ian L Ross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ross I, Le H, Budiman S, Xiong D, Hemker F, Millen E, et al.
Plant Physiol
. 2024 Aug;
196(4):2330-2345.
PMID: 39179421
CRISPR/Cas9 gene editing in the model green alga Chlamydomonas reinhardtii relies on the use of selective marker genes to enrich for nonselectable target mutations. This becomes challenging when many sequential...
2.
de Villiers O, Elliot-Wilson C, Thomas K, Semple P, Naiker T, Henry M, et al.
PLoS One
. 2024 Jan;
19(1):e0296387.
PMID: 38236816
Strong lines of evidence in the neuroscience literature indicate that (a) healthy sleep facilitates cognitive processing, and (b) sleep disruption is associated with cognitive dysfunction. Despite the fact that patients...
3.
Wearne N, Davidson B, Blockman M, Jones J, Ross I, Dave J
HIV AIDS (Auckl)
. 2023 Sep;
15:519-535.
PMID: 37700755
There is an increasing global burden of diabetes mellitus (DM) and chronic kidney disease (CKD), coupled with a high burden of people with HIV (PWH). Due to an increased lifespan...
4.
Williamson E, Ross I, Wall B, Hankamer B
Trends Plant Sci
. 2023 Sep;
29(3):370-382.
PMID: 37690907
To support a global population of ~10 billion people in 2050, dietary protein demand is forecast to increase 32-78% compared to 2017, requiring significantly higher planetary resources. Microalgae are an...
5.
Nowotny H, Bryce J, Ali S, Giordano R, Baronio F, Chifu I, et al.
Endocr Connect
. 2023 Jan;
12(4).
PMID: 36715679
Background: Information on clinical outcomes of coronavirus disease 19 (COVID-19) infection in patients with adrenal disorders is scarce. Methods: A collaboration between the European Society of Endocrinology (ESE) Rare Disease...
6.
Mofokeng T, Beshyah S, Ross I
Int J Endocrinol
. 2022 Sep;
2022:8907864.
PMID: 36060294
Backgrounds: Africa comprises 54 countries with varying degrees of economic development. As with other healthcare systems, rare diseases such as adrenal insufficiency are neglected and poorly documented. Objectives: We wished...
7.
Bezuidenhout M, Conradie-Smit M, Dave J, De Vries E, Ross I, Zemlin A
Ann Clin Biochem
. 2022 Jan;
59(3):183-192.
PMID: 35044249
Background: Hormone therapy in transgender individuals may impact processes that lead to changes in biochemical analytes, and therefore reference intervals. Currently, few reference interval studies are available for the transgender...
8.
Dave J, Tamuhla T, Tiffin N, Levitt N, Ross I, Toet W, et al.
Diabetes Res Clin Pract
. 2021 Jun;
177:108925.
PMID: 34166703
Background: COVID-19 outcomes and risk factors, including comorbidities and medication regimens, in people living with diabetes (PLWD) are poorly defined for low- and middle-income countries. Methods: The Provincial Health Data...
9.
Ross I, Shah S, Hankamer B, Amiralian N
Trends Plant Sci
. 2021 Jun;
26(9):924-939.
PMID: 34144878
Over 3 billion years, photosynthetic algae have evolved complex uses for cellulose, the most abundant polymer worldwide. A major cell-wall component of lignocellulosic plants, seaweeds, microalgae, and bacteria, cellulose can...
10.
Mofokeng T, Ndlovu K, Beshyah S, Ross I
PLoS One
. 2020 Nov;
15(11):e0241845.
PMID: 33152017
Objective: We wished to determine the prevalence, etiology, presentation, and available management strategies for primary adrenal insufficiency (PAI) in South Africa (SA), hypothesizing a prevalence greater than the described 3.1...